These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35655816)

  • 1. Cut-off values for low skeletal muscle mass at the level of the third cervical vertebra (C3) in patients with head and neck cancer.
    Chargi N; Bril SI; Smid EJ; de Jong PA; de Bree R
    Quant Imaging Med Surg; 2022 Jun; 12(6):3024-3033. PubMed ID: 35655816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of skeletal muscle mass assessment at the level of the third cervical vertebra in patients with head and neck cancer.
    Bril SI; Chargi N; Wendrich AW; Wegner I; Bol GH; Smid EJ; de Jong PA; Devriese LA; de Bree R
    Oral Oncol; 2021 Dec; 123():105617. PubMed ID: 34749251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CT-measured skeletal muscle mass used to assess frailty in patients with head and neck cancer.
    Zwart AT; van der Hoorn A; van Ooijen PMA; Steenbakkers RJHM; de Bock GH; Halmos GB
    J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):1060-1069. PubMed ID: 31134765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skeletal muscle mass and sarcopenia can be determined with 1.5-T and 3-T neck MRI scans, in the event that no neck CT scan is performed.
    Zwart AT; Becker JN; Lamers MJ; Dierckx RAJO; de Bock GH; Halmos GB; van der Hoorn A
    Eur Radiol; 2021 Jun; 31(6):4053-4062. PubMed ID: 33219847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sarcopenia may predict recurrence in patients with head and neck cancer.
    Colback AA; Arkfeld DV; Paydar A; Raslan O; Cates DJ; Abouyared M
    Head Neck; 2025 Jan; 47(1):282-288. PubMed ID: 39138607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of using head and neck CT imaging to assess skeletal muscle mass in head and neck cancer patients.
    Swartz JE; Pothen AJ; Wegner I; Smid EJ; Swart KM; de Bree R; Leenen LP; Grolman W
    Oral Oncol; 2016 Nov; 62():28-33. PubMed ID: 27865369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining reference values for low skeletal muscle index at the L3 vertebra level based on computed tomography in healthy adults: A multicentre study.
    Kong M; Geng N; Zhou Y; Lin N; Song W; Xu M; Li S; Piao Y; Han Z; Guo R; Yang C; Luo N; Wang Z; Jiang M; Wang L; Qiu W; Li J; Shi D; Li R; Cheung EC; Chen Y; Duan Z
    Clin Nutr; 2022 Feb; 41(2):396-404. PubMed ID: 34999334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of skeletal muscle mass on dose-limiting toxicities during (chemo)radiotherapy in patients with head and neck cancer: A systematic review and meta-analysis.
    Schaeffers AWMA; Scholten HA; van Beers MA; Meussen BW; Smid EJ; van Gils CH; Devriese LA; de Bree R
    Oral Oncol; 2024 Oct; 157():106978. PubMed ID: 39111144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interobserver agreement of skeletal muscle mass measurement on head and neck CT imaging at the level of the third cervical vertebra.
    Bril SI; Wendrich AW; Swartz JE; Wegner I; Pameijer F; Smid EJ; Bol GH; Pothen AJ; de Bree R
    Eur Arch Otorhinolaryngol; 2019 Apr; 276(4):1175-1182. PubMed ID: 30689037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effectiveness of skeletal muscle evaluation at the third cervical vertebral level for computed tomography-defined sarcopenia assessment in patients with head and neck cancer.
    Vangelov B; Bauer J; Moses D; Smee R
    Head Neck; 2022 May; 44(5):1047-1056. PubMed ID: 35138008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Value of Third Cervical Vertebra Skeletal Muscle Index in Oral Cavity Cancer: A Retrospective Study.
    Chang SW; Hsu CM; Tsai YH; Chang GH; Tsai MS; Huang EI; Tsai YT
    Laryngoscope; 2021 Jul; 131(7):E2257-E2265. PubMed ID: 33433021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence to a standardized protocol for measuring grip strength and appropriate cut-off values in adults over 65 years with sarcopenia: a systematic review protocol.
    Fox B; Henwood T; Schaap L; Bruyère O; Reginster JY; Beaudart C; Buckinx F; Roberts H; Cooper C; Cherubini A; dellʼAquilla G; Maggio M; Volpato S
    JBI Database System Rev Implement Rep; 2015 Oct; 13(10):50-9. PubMed ID: 26571282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of Skeletal Muscle Depletion on Head and Neck Squamous Cell Carcinoma.
    Nishikawa D; Hanai N; Suzuki H; Koide Y; Beppu S; Hasegawa Y
    ORL J Otorhinolaryngol Relat Spec; 2018; 80(1):1-9. PubMed ID: 29393251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low skeletal muscle mass is a predictive factor for chemotherapy dose-limiting toxicity in patients with locally advanced head and neck cancer.
    Wendrich AW; Swartz JE; Bril SI; Wegner I; de Graeff A; Smid EJ; de Bree R; Pothen AJ
    Oral Oncol; 2017 Aug; 71():26-33. PubMed ID: 28688687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of Sarcopenia in Head and Neck Computed Tomography: Cervical Muscle Mass as a Strong Indicator of Sarcopenia.
    Ufuk F; Herek D; Yüksel D
    Clin Exp Otorhinolaryngol; 2019 Aug; 12(3):317-324. PubMed ID: 30947498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deep learning auto-segmentation of cervical skeletal muscle for sarcopenia analysis in patients with head and neck cancer.
    Naser MA; Wahid KA; Grossberg AJ; Olson B; Jain R; El-Habashy D; Dede C; Salama V; Abobakr M; Mohamed ASR; He R; Jaskari J; Sahlsten J; Kaski K; Fuller CD
    Front Oncol; 2022; 12():930432. PubMed ID: 35965493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sarcopenia in head and neck cancer: A scoping review.
    Jovanovic N; Chinnery T; Mattonen SA; Palma DA; Doyle PC; Theurer JA
    PLoS One; 2022; 17(11):e0278135. PubMed ID: 36441690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Masseter muscle parameters can function as an alternative for skeletal muscle mass assessments on cross-sectional imaging at lumbar or cervical vertebral levels.
    van Heusden HC; Chargi N; Dankbaar JW; Smid EJ; de Bree R
    Quant Imaging Med Surg; 2022 Jan; 12(1):15-27. PubMed ID: 34993057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of head and neck computed tomography for skeletal muscle mass estimation in patients with head and neck cancer.
    Jung AR; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2019 Aug; 95():95-99. PubMed ID: 31345401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment and Validation of Pre-Therapy Cervical Vertebrae Muscle Quantification as a Prognostic Marker of Sarcopenia in Patients With Head and Neck Cancer.
    Olson B; Edwards J; Degnin C; Santucci N; Buncke M; Hu J; Chen Y; Fuller CD; Geltzeiler M; Grossberg AJ; Clayburgh D
    Front Oncol; 2022; 12():812159. PubMed ID: 35237517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.